Status:
COMPLETED
IV Insulin Protocol in Diabetes and Renal Transplantation
Lead Sponsor:
Medical University of South Carolina
Conditions:
Kidney Transplantation
Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Purpose: The purpose of this study is to provide tight blood sugar control using insulin given through the veins at the time of kidney transplantation and up to 3 days after surgery. After release fro...
Detailed Description
Research Design: A randomized control trial comparing intensive intravenous insulin (IVI) for use in the hospital followed by intensive subcutaneous (sc) insulin use for in-patient and out-patient gly...
Eligibility Criteria
Inclusion
- 18 years of age and greater,
- Diabetes diagnosis (Type 1 and Type 2, awaiting a living or cadaveric renal transplant, renal transplant candidates admitted to MUSC medical center for a donor kidney, FBG \>100 mg/dL per admission screening labs, random BG \>120mg/dL per admission screening labs, and
- Willing and able to provide informed consent
Exclusion
- History of an active GI bleed in the previous 3 mos,
- Scheduled to receive a simultaneous pancreas transplant,
- History of a functioning pancreatic transplant,
- Patient currently managed on an insulin pump,
- Unable or unwilling to provide informed consent, and
- Unable to commit to the study protocol including the outpatient follow-up phase of care
Key Trial Info
Start Date :
July 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT00609986
Start Date
July 1 2007
End Date
October 1 2010
Last Update
September 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29464